2024 annual financial data
RenovoRx, Inc. 2024 Operating margin
RenovoRx, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was -25,511.63%.
Operating income was -10,970,000 USD and net income was -8,814,000 USD.
Operating cash flow was -9,125,000 USD.
Get free RenovoRx, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 43,000 USD
- Operating income
- -10,970,000 USD
- Net income
- -8,814,000 USD
- Operating cash flow
- -9,125,000 USD